ARCHIVES

The Clinical Trials Working Group: NCI panel considers plan to centralize clinical trial review and prioritization. NCI director faults system for duplication, “equivocal results.”

This article is from The Cancer Letter archive.

Vol. 30 No. 33 | August 13, 2004

Download PDF Visit The Full Archive

Related Articles

In Brief: Lippman Leads M.D. Anderson Clinical Prevention; Baylin Named Ludwig Professor

May 10, 1996

In Brief: Durant New President Of AACI, Ultmann Named President-Elect; Farber Center Gets New Name

February 4, 1983

Nancy Davidson Elected ASCO President.

March 3, 2006

House Members Who Voted for Veto

January 3, 1986

In Phase II Study, NKTR-102 Shows Objective Response

January 28, 2011

FDA Approvals: Lymphoseek Label Updated to Include Head and Neck SCC

June 27, 2014